<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39374820</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1519</ISSN><JournalIssue CitedMedium="Internet"><Volume>331</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Respiratory physiology &amp; neurobiology</Title><ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Inspiratory muscle training improves autonomic function in myalgic encephalomyelitis/chronic fatigue syndrome and post-acute sequelae of SARS-CoV-2: A pilot study.</ArticleTitle><Pagination><StartPage>104360</StartPage><MedlinePgn>104360</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resp.2024.104360</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1569-9048(24)00153-8</ELocationID><Abstract><AbstractText>Post-acute sequelae of SARS-CoV-2 (PASC), or Long COVID, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are debilitating post-viral conditions with many symptomatic overlaps, including exercise intolerance and autonomic dysfunction. Both conditions are growing in prevalence, and effective safe treatment strategies must be investigated. We hypothesized that inspiratory muscle training (IMT) could be used in PASC and mild to moderate ME/CFS to mitigate symptoms, improve exercise capacity, and improve autonomic function. We recruited healthy controls (n=12; 10 women), people with PASC (n=9; 8 women), and people with mild to moderate ME/CFS (n=12; 10 women) to complete 8 weeks of IMT. This project was registered as a clinical trial (NCT05196529) with clinicaltrials.gov. After completion of IMT, all groups experienced improvements in inspiratory muscle pressure (p&lt;0.001), 6-minute walk distance (p=0.002), resting heart rate (p=0.037), heart rate variability (p&lt;0.05), and symptoms related to sleep (p=0.009). In the ME/CFS group only, after completion of IMT, there were additional improvements with regard to vascular function (p=0.001), secretomotor function (p=0.023), the total weighted score (p=0.005) of the COMPASS 31 autonomic questionnaire, and symptoms related to pain (p=0.016). We found that after 8 weeks of IMT, people with PASC and/or ME/CFS could see some overall improvements in their autonomic function and symptomology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edgell</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Kinesiology and Health Science, York University,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada; Muscle Health Research Centre, York University,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada; ICanCME Research Network,&#xa0;Montreal,&#xa0;Quebec,&#xa0;Canada. Electronic address: edgell@yorku.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Tania J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>School of Kinesiology and Health Science, York University,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Environmental Health Clinic, Women's College Hospital,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada; ICanCME Research Network,&#xa0;Montreal,&#xa0;Quebec,&#xa0;Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Riina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Environmental Health Clinic, Women's College Hospital,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada; ICanCME Research Network,&#xa0;Montreal,&#xa0;Quebec,&#xa0;Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabassum</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Environmental Health Clinic, Women's College Hospital,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada; ICanCME Research Network,&#xa0;Montreal,&#xa0;Quebec,&#xa0;Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sergio</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Kinesiology and Health Science, York University,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badhwar</LastName><ForeName>Smriti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Kinesiology and Health Science, York University,&#xa0;Toronto,&#xa0;Ontario,&#xa0;Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05196529</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Respir Physiol Neurobiol</MedlineTA><NlmUniqueID>101140022</NlmUniqueID><ISSNLinking>1569-9048</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic</Keyword><Keyword MajorTopicYN="N">Inspiratory muscle training</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">Symptomology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39374820</ArticleId><ArticleId IdType="doi">10.1016/j.resp.2024.104360</ArticleId><ArticleId IdType="pii">S1569-9048(24)00153-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>